Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Condition: Healthy Subjects Interventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2016 Category: Research Source Type: clinical trials
Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial
This study is a prospective, single-center, open-label, randomized controlled clinical trial aimed at exploring the efficacy of olmesartan medoxomil on coronary atherosclerosis and EAT. A total of 194 patients with coronary stenosis greater than 30 % and less than 70 % detected by CCTA will be randomly divided into olmesartan medoxomil or conventional antihypertensive medication groups (1:1 ratio). The primary outcome measures include coronary atherosclerosis progression and EAT volume reduction, as detected by CCTA at 12 months. The secondary outcome measures include the levels of blood lipids, glucose, high-sensitivit...
Source: Trials - January 6, 2016 Category: Research Source Type: clinical trials
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
Condition: HealthyInterventions: Drug: Olostar Tab.; Drug: Co-administration of Olmetec and CrestorSponsor: Daewoong Pharmaceutical Co. LTD.Enrolling by invitation - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2015 Category: Research Source Type: clinical trials
